Mandibular advancement device: prescription in adult dental sleep medicine - guideline of the German Society of Dental Sleep Medicine.

PURPOSE: Obstructive sleep apnea (OSA) may result in severe health onditions, reduces quality of live, and affects high percentages of the adult population. Due to recent changes in the German health care regulations, mandibular advancement devices (MAD) will become available as a treatment option for OSA to a greater extent for general dentists and their patients. METHODS: A guideline development group consisting of nine members representing four German dental and medical organizations was formed, in order to provide critical information and orientation to the main stakeholders (dentists and patients), regarding the use of MAD for the treatment of OSA within dental sleep medicine. RESULTS: This guideline aims to inform physicians and dentists, particularly those with acquired qualification/specialization in sleep medicine (or in the diagnosis and treatment of sleep-related breathing disorders), as well as experts, payers, and patients. It delivers recommendations on technical requirements for MAD prescription and fabrication, clinical procedures, maintenance, and follow-up procedures. CONCLUSION: A MAD should be designed for long-term therapy and must be a custom made, adjustable, bimaxillary retained two-splint system equipped with adjustable protrusive elements. The fabrication in a dental laboratory should be based on dental impressions or scans and three-dimensional registrations of the starting position taken with a bite gauge.

Chronic stress and temporalis muscle activity in TMD patients and controls during sleep: a pilot study in females.

OBJECTIVES: The aim of this study was to assess the correlation between chronic stress and temporalis muscle activity during four nights. MATERIAL AND METHODS: Forty-four female subjects were recruited in five dental practices located in different areas of the federal state of Saarland, Germany (dental practice network in Saarland). The following inclusion criteria were used: female, aged between 18 and 65, no somatization or depression, and no pain medication, graded chronic pain status < 3. Both subjects reporting about sleep bruxism and subjects negating sleep bruxism during anamnesis were included. Anamnestic issues, sleep bruxism, anxiety, and chronic stress were assessed using validated questionnaires. Temporalis muscle activity was measured for four nights using a portable electromyographic device. Correlation coefficient was used to assess the correlation (Spearman-correlation) between chronic stress and number of temporalis muscle episodes/hour and between anxiety and the number of episodes/hour. RESULTS: The analysis showed that the factors "work overload" (adulthood chronic stress because of too many demands at work) and "pressure to perform" (necessity to be successful at work) were significantly correlated with the number of temporalis muscle episodes per hour. In contrast, anxiety was not correlated with temporalis muscle episodes per hour. CONCLUSIONS: Work-related chronic stress seems to be associated with an increased level of temporalis muscle activity during sleep. CLINICAL RELEVANCE: During anamnesis, work-related aspects should be assessed in females presenting with sleep-bruxism.

Sleep-associated aspects of myofascial pain in the orofacial area among Temporomandibular Disorder patients and controls.

STUDY OBJECTIVES: To assess sleep-associated aspects of temporomandibular disorder (TMD) with myofascial pain (MP) in the orofacial area of patients and controls. MEASUREMENTS: Three hundred five female patients were screened to find 44 participants fulfilling the inclusion criteria, 22 suffering from MP and 22 in a control group. Sleep quality was assessed by use of the Pittsburgh Sleep-Quality-Index (PSQI) and a validated German sleep questionnaire (SF-AR). Tooth wear was assessed and anterior temporalis muscle activity was measured at home for several nights by use of a portable electromyography (EMG) device. RESULTS: 22 patients (45.0 ± 13.6 years) and 22 controls (45.2 ± 9.0 years) were recruited. The PSQI sum-score was 7.5 ± 3.7 for patients and 4.4 ± 3.0 for controls (p = 0.006). The SF-AR showed that 23% of the controls and 14% of the patients were "long sleepers". The overall number of episodes in the two groups was not significantly different (4.10 ± 2.65 versus 4.57 ± 1.99 episodes per hour). However, more patients had temporalis muscle activity possibly related to SB during all four consecutive nights (p = 0.04). According to the International Classification of Sleep Disorders - Third Edition (ICSD-3) criteria, 13.6% of the controls and 71.4% of the patients (p < 0.001) showed SB. CONCLUSIONS: Sleep-associated disturbances, including reduction of sleep quality and greater prevalence of SB and facial pain in the morning, occurred significantly more often among TMD patients. Additionally, SB fluctuated over the nights especially in controls. This should be taken into consideration when the prevalence of SB is assessed by use of EMG.